• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金属蛋白酶组织抑制剂2在肿瘤微环境中的分子机制

Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment.

作者信息

Remillard Taylor C, Bratslavsky Gennady, Jensen-Taubman Sandra, Stetler-Stevenson William G, Bourboulia Dimitra

机构信息

Department of Urology, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210 USA.

Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Advanced Technology Center, 8717 Grovemont Circle, Bethesda, MD 20892-4605 USA.

出版信息

Mol Cell Ther. 2014 Jun 3;2:17. doi: 10.1186/2052-8426-2-17. eCollection 2014.

DOI:10.1186/2052-8426-2-17
PMID:26056585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4452049/
Abstract

There has been a recent paradigm shift in the way we target cancer, drawing a greater focus on the role of the tumor microenvironment (TME) in cancer development, progression and metastasis. Within the TME, there is a crosstalk in signaling and communication between the malignant cells and the surrounding extracellular matrix. Matrix metalloproteinases (MMPs) are zinc-dependent endoproteases that have the ability to degrade the matrix surrounding a tumor and mediate tumor growth, angiogenesis and metastatic disease. Their endogenous inhibitors, the Tissue Inhibitors of Metalloproteinases (TIMPs), primarily function to prevent degradation of the ECM via inhibition of MMPs. However, recent studies demonstrate that TIMP family members also possess MMP-independent functions. One TIMP member in particular, TIMP-2, has many distinct properties and functions, that occur independent of MMP inhibition, including the inhibition of tumor growth and reduction of angiogenesis through decreased endothelial cell proliferation and migration. The MMP-independent molecular mechanisms and signaling pathways elicited by TIMP-2 in the TME are described in this review.

摘要

近年来,我们针对癌症的方式发生了范式转变,更加关注肿瘤微环境(TME)在癌症发生、发展和转移中的作用。在TME中,恶性细胞与周围细胞外基质之间存在信号传导和通讯的相互作用。基质金属蛋白酶(MMPs)是锌依赖性内切蛋白酶,能够降解肿瘤周围的基质并介导肿瘤生长、血管生成和转移性疾病。它们的内源性抑制剂——金属蛋白酶组织抑制剂(TIMPs),主要功能是通过抑制MMPs来防止细胞外基质的降解。然而,最近的研究表明,TIMP家族成员还具有不依赖MMP的功能。特别是一种TIMP成员TIMP-2,具有许多独特的特性和功能,这些特性和功能独立于MMP抑制作用而发生,包括通过减少内皮细胞增殖和迁移来抑制肿瘤生长和减少血管生成。本文综述了TIMP-2在TME中引发的不依赖MMP的分子机制和信号通路。

相似文献

1
Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment.金属蛋白酶组织抑制剂2在肿瘤微环境中的分子机制
Mol Cell Ther. 2014 Jun 3;2:17. doi: 10.1186/2052-8426-2-17. eCollection 2014.
2
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.基质金属蛋白酶及其抑制剂在人类疾病中的作用。
Int J Mol Sci. 2020 Dec 20;21(24):9739. doi: 10.3390/ijms21249739.
3
Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic.肿瘤微环境的正常化:组织金属蛋白酶抑制剂-2 作为癌症治疗的证据。
Connect Tissue Res. 2014 Jan-Feb;55(1):13-9. doi: 10.3109/03008207.2013.867339.
4
The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2.肿瘤微环境:金属蛋白酶组织抑制剂-2的非基质金属蛋白酶依赖性效应的调节作用
Cancer Metastasis Rev. 2008 Mar;27(1):57-66. doi: 10.1007/s10555-007-9105-8.
5
Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.乳腺癌肿瘤组织标本以及具有不同转移潜能的细胞系中基质金属蛋白酶与其抑制剂之间的相关性。
BMC Cancer. 2009 Jan 14;9:20. doi: 10.1186/1471-2407-9-20.
6
Engineering minimal tissue inhibitors of metalloproteinase targeting MMPs via gene shuffling and yeast surface display.通过基因改组和酵母表面展示工程化最小组织金属蛋白酶抑制剂靶向 MMPs。
Protein Sci. 2023 Dec;32(12):e4795. doi: 10.1002/pro.4795.
7
Matrix metalloproteinase inhibitors.基质金属蛋白酶抑制剂
Invest New Drugs. 1997;15(1):61-75. doi: 10.1023/a:1005722729132.
8
Selected Matrix Metalloproteinases (MMP-2, MMP-7) and Their Inhibitor (TIMP-2) in Adult and Pediatric Cancer.成人和儿童癌症中的特定基质金属蛋白酶(MMP - 2、MMP - 7)及其抑制剂(TIMP - 2)
Diagnostics (Basel). 2020 Jul 31;10(8):547. doi: 10.3390/diagnostics10080547.
9
Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.由激活基质金属蛋白酶及其抑制剂的信号通路驱动的肿瘤进展。
J Oral Pathol Med. 2015 Jul;44(6):437-43. doi: 10.1111/jop.12270. Epub 2014 Sep 22.
10
Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation.金属蛋白酶组织抑制剂(TIMP)在侵袭和增殖中的作用
APMIS. 1999 Jan;107(1):111-9. doi: 10.1111/j.1699-0463.1999.tb01533.x.

引用本文的文献

1
TIMP-1 and its potential diagnostic and prognostic value in pulmonary diseases.基质金属蛋白酶组织抑制因子-1及其在肺部疾病中的潜在诊断和预后价值。
Chin Med J Pulm Crit Care Med. 2023 Jun;1(2):67-76. doi: 10.1016/j.pccm.2023.05.002. Epub 2023 Jun 19.
2
Noncanonical Activity of Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Improves Cognition and Synapse Density in Aging.组织金属蛋白酶抑制剂 2(TIMP2)的非典型活性可改善衰老过程中的认知和突触密度。
eNeuro. 2023 Jun 15;10(6). doi: 10.1523/ENEURO.0031-23.2023. Print 2023 Jun.
3
Next generation oncolytic viruses expressing PADI1 and TIMP2 exhibit anti-tumor activity against melanoma in nude and humanized mouse models.表达PADI1和TIMP2的新一代溶瘤病毒在裸鼠和人源化小鼠模型中对黑色素瘤具有抗肿瘤活性。
Mol Ther Oncolytics. 2023 Jan 13;28:158-170. doi: 10.1016/j.omto.2023.01.002. eCollection 2023 Mar 16.
4
Impact of Co-chaperones and Posttranslational Modifications Toward Hsp90 Drug Sensitivity.共伴侣蛋白和翻译后修饰对Hsp90药物敏感性的影响
Subcell Biochem. 2023;101:319-350. doi: 10.1007/978-3-031-14740-1_11.
5
The Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation?慢性炎症中细胞外基质的研究:预防癌症发生的一种途径?
Cancers (Basel). 2022 Nov 29;14(23):5903. doi: 10.3390/cancers14235903.
6
TIMP1 and TIMP2 Downregulate TGFβ Induced Decidual-like Phenotype in Natural Killer Cells.金属蛋白酶组织抑制因子1和金属蛋白酶组织抑制因子2下调自然杀伤细胞中转化生长因子β诱导的蜕膜样表型。
Cancers (Basel). 2021 Oct 1;13(19):4955. doi: 10.3390/cancers13194955.
7
MMPs, tyrosine kinase signaling and extracellular matrix proteolysis in kidney cancer.MMPs、酪氨酸激酶信号通路与肾癌细胞外基质的降解
Urol Oncol. 2021 Jun;39(6):316-321. doi: 10.1016/j.urolonc.2020.04.034. Epub 2020 May 31.
8
Matrisome-Associated Gene Expression Patterns Correlating with TIMP2 in Cancer.基质相关基因表达模式与癌症中 TIMP2 的相关性。
Sci Rep. 2019 Dec 27;9(1):20142. doi: 10.1038/s41598-019-56632-3.
9
TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer.TIMP-2 抑制三阴性乳腺癌小鼠模型中的肿瘤生长和转移。
Carcinogenesis. 2020 May 14;41(3):313-325. doi: 10.1093/carcin/bgz172.
10
Emphysema phenotypes and lung cancer risk.肺气肿表型与肺癌风险。
PLoS One. 2019 Jul 25;14(7):e0219187. doi: 10.1371/journal.pone.0219187. eCollection 2019.

本文引用的文献

1
Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma.金属蛋白酶组织抑制因子-2表达降低与晚期甲状腺髓样癌相关。
Oncol Lett. 2014 Mar;7(3):731-737. doi: 10.3892/ol.2013.1767. Epub 2013 Dec 19.
2
TIMP-2-derived 18-mer peptide inhibits endothelial cell proliferation and migration through cAMP/PKA-dependent mechanism.TIMP-2 衍生的 18 肽通过 cAMP/PKA 依赖性机制抑制内皮细胞增殖和迁移。
Cancer Lett. 2014 Feb 28;343(2):210-6. doi: 10.1016/j.canlet.2013.10.037. Epub 2013 Nov 16.
3
An endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells.一种内源性血管生成抑制剂与人肺癌细胞中的侧群表型和功能呈负相关。
Oncogene. 2014 Feb 27;33(9):1198-206. doi: 10.1038/onc.2013.61. Epub 2013 Mar 11.
4
TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells.基质金属蛋白酶组织抑制因子-2调节A549肺癌细胞的转录谱并增强E-钙黏蛋白/β-连环蛋白复合物的表达。
Oncotarget. 2013 Jan;4(1):166-76. doi: 10.18632/oncotarget.801.
5
Antagonism of VEGF-A-induced increase in vascular permeability by an integrin α3β1-Shp-1-cAMP/PKA pathway.整合素 α3β1-Shp-1-cAMP/PKA 通路拮抗 VEGF-A 诱导的血管通透性增加。
Blood. 2012 Dec 6;120(24):4892-902. doi: 10.1182/blood-2012-05-428243. Epub 2012 Oct 16.
6
TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis.TIMP-2 靶向肿瘤相关的髓系抑制细胞,对癌症免疫功能障碍和血管生成具有影响。
J Immunother. 2012 Jul;35(6):502-12. doi: 10.1097/CJI.0b013e3182619c8e.
7
The extracellular matrix: a dynamic niche in cancer progression.细胞外基质:癌症进展中的动态生态位。
J Cell Biol. 2012 Feb 20;196(4):395-406. doi: 10.1083/jcb.201102147.
8
Tissue inhibitors of metalloproteinases.金属蛋白酶组织抑制剂。
Genome Biol. 2011 Nov 11;12(11):233. doi: 10.1186/gb-2011-12-11-233.
9
EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment.EFEMP1 抑制恶性神经胶质瘤的生长,并在肿瘤细胞外基质中发挥作用。
Mol Cancer. 2011 Sep 28;10:123. doi: 10.1186/1476-4598-10-123.
10
Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment.内源性血管生成抑制剂通过对肿瘤微环境的直接和间接作用来抑制肿瘤生长。
Am J Pathol. 2011 Nov;179(5):2589-600. doi: 10.1016/j.ajpath.2011.07.035. Epub 2011 Sep 18.